| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -6% |
| 3Y CAGR | -7.0% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -31% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,386.30 -134.00 (5.32%) | 19,162.17 | 28.26 | 5.69 | ||
PfizerPFIZER | ₹3,864.40 -28.90 (0.74%) | 17,811.42 | 20.73 | 4.06 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,438.50 -68.50 (1.05%) | 16,277.75 | 91.59 | 18.52 | ||
Natco PharmaNATCOPHARM | ₹808.80 -0.15 (0.02%) | 15,862.14 | 13.86 | 1.51 |